Trial site
Central Texas Neurology Consultants
- 9running trials
- 12closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Parkinson disease10 trials
- Alzheimer disease6 trials
- Multiple sclerosis3 trials
- Lewy body dementia1 trial
- Mild cognitive impairment1 trial
- Neuromyelitis optica (NMOSD)1 trial
- Spinal muscular atrophy1 trial
- Phase
- Phase 29 trials
- Phase 38 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed11 trials
- Active, not recruiting6 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche5 trials
- Eli Lilly and Company3 trials
- Annovis Bio Inc.2 trials
- Biogen2 trials
- Cerevance1 trial
- and 8 more
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Recruiting
Active, not recruiting
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
Recruiting
Active, not recruiting
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Parkinson disease2 recruiting
- Alzheimer disease1 recruiting
- Lewy body dementia1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Completed
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
Completed
Completed
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Completed
A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease
Completed
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Completed
Completed
Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)
Completed
Completed
Completed
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Site data: ClinicalTrials.govUpdated 18 Nov 2026